We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/1/2017 07:44 | Sounds a great appointment to add to the recruitment of the superdrug member of staff. | doc robinson | |
30/1/2017 07:25 | RNS 30 yrs experience a nice hire | nw99 | |
29/1/2017 20:49 | Doc it's a buy here go for it | nw99 | |
29/1/2017 12:25 | Will top up first thing these were 2.65 2 weeks ago suggest a bit overdone. | doc robinson | |
29/1/2017 09:53 | Wrong thread! | allstar4eva | |
29/1/2017 09:49 | May dip my toe into these, very risky though imo | malcolmmm | |
29/1/2017 06:37 | Andyr42 you really are a numpty | reallyrich | |
28/1/2017 18:45 | Should be a strong recovery leading up to results day news potentially on several fronts. As advised any sustained buying will push this up fast . | doc robinson | |
27/1/2017 16:36 | Strong finish. Abodes well for next week. Have a good one those who stayed true. | andyr42 | |
27/1/2017 15:58 | CSM agreed | nw99 | |
27/1/2017 15:47 | Don't worry nw99 I still here too just not been on here for a while, not expecting big bucks every week just get feeling longer term this will go back higher and further than it has before roll on the results hopefully some good news about United States will be forthcoming | csmwssk12hu | |
27/1/2017 15:28 | Still in I believe. | luminoso | |
27/1/2017 15:26 | Raise more wonga? Is Kelly Hoppen still invested or cashed in? | ny boy | |
27/1/2017 15:10 | ... and how they are going to fund their growth ? | luminoso | |
27/1/2017 14:54 | it is the outlook for 17 and beyond IMO that will be key, recent TU is priced into the market, it is the new news that will move it up or down....needs to think about its messaging very carefully IMO!....gla | qs99 | |
27/1/2017 14:49 | its all just betting on numbers game nowadays is it going up or down ! | arab3 | |
27/1/2017 14:44 | exactly arab, the chart is very weak, a bounce like this after such a fall may not be a bounce with strength, we shall see! The results make me slightly nervous - we all thought the trading update would make the stock rocket but it was like the Trident missile! | che7win | |
27/1/2017 14:41 | or just keep buying and selling as you do . lol | arab3 | |
27/1/2017 14:38 | It's forecast to make 4.9p this year, so P/E is 28 at 137p, I think those that look at 270p and think it's cheap here need to be very careful. I talk from experience in losing elsewhere, so I'm going to protect capital first. I'm not emotional to any stock, this stock doesn't 'owe' anyone anything, so stay ruthless and don't get too over exposed! | che7win | |
27/1/2017 14:33 | I was worried I was the only holder for a while earlier this week but stuck to my guns ! | nw99 | |
27/1/2017 14:32 | well done nw99 the only true holder here ! | arab3 | |
27/1/2017 14:30 | Nice one I am holding for a considerable amount more | nw99 | |
27/1/2017 14:29 | Closed for 25% will have another go if the market allows me GL | ny boy | |
27/1/2017 14:28 | 25% up today Intra day agreed is a good start but look where it has fallen from p,entry more upside to come | nw99 | |
27/1/2017 14:21 | You've got focus on the market cap, forget the share price for time being. Its so incredibly low. What should it be? I don't know I am not an Analyst of these stocks but for a global brand it should be much higher, £50M? | andyr42 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions